期刊文献+
共找到347篇文章
< 1 2 18 >
每页显示 20 50 100
Do changes in intracoronary pressure aid coronary spasm diagnosis using the spasm provocation test?
1
作者 Hiroki Teragawa Chikage Oshita Yuko Uchimura 《World Journal of Cardiology》 2024年第1期16-26,共11页
BACKGROUND Although the spasm provocation test(SPT)can diagnose coronary spasms,it would be helpful if it could also predict their occurrence.AIM To investigate whether coronary spasms can be predicted using changes i... BACKGROUND Although the spasm provocation test(SPT)can diagnose coronary spasms,it would be helpful if it could also predict their occurrence.AIM To investigate whether coronary spasms can be predicted using changes in intracoronary artery pressure measured using a pressure wire during the SPT.METHODS Seventy patients underwent SPTs with pressure-wire measurement of intracoronary artery pressure.During each SPT,the pressure wire was advanced into the distal portion of the right coronary artery(RCA)and left anterior descending coronary artery,and the ratio of intracoronary pressure to aortic pressure(Pd/Pa)was monitored.Coronary spasm was defined as an arterial narrowing of>90%in response to the administration of acetylcholine(ACh),with chest symptoms and/or ischemic electrocardiographic changes.ACh was administered to the RCA at low,moderate,or high doses of 20,50,or 80μg,respectively,and to the left coronary artery(LCA)at low,moderate,or high doses of 50,100,or 200μg,respectively.Coronary arteries with coronary spasms at low doses of ACh were defined as group L,and those with coronary spasms at moderate or high doses were defined as group MH.Those who did not occur coronary spasms at any ACh dose were designated as group N.RESULTS Among the 132 coronary arteries assessed using a pressure wire,there were 49 in group N,25 in group L,and 58 in group MH.Baseline Pd/Pa was the lowest in group L(P=0.001).The decrease in the Pd/Pa between baseline to low doses of ACh was lower in group MH than in group N(P<0.001).A receiver-operating characteristics analysis showed that the cutoff baseline Pd/Pa value for predicting group L was 0.95,with a sensitivity of 0.600(15/25)and a specificity of 0.713(76/107)and that the cutoff value of Pd/Pa from baseline to low doses of ACh for predicting group MH was−0.04,with a sensitivity of 0.741(43/58)and a specificity of 0.694(34/49).CONCLUSION These findings suggest that indices of intracoronary pressure during SPT may be useful means for predicting the occurrence of coronary spasms. 展开更多
关键词 ACETYLCHOLINE Coronary spasm intracoronary pressure Pressure wire Spasm provocation test Vasospastic angina
下载PDF
Does the intracoronary pressure differ according to two types(diffuse or focal)of coronary spasm? 被引量:1
2
作者 Hiroki Teragawa Chikage Oshita Yuko Uchimura 《World Journal of Cardiology》 2023年第1期1-12,共12页
BACKGROUND Several reports show that two types of coronary vasospasm(diffuse and focal spasm)are associated with the severity or prognosis of coronary spasm in patients with vasospastic angina(VSA).It is unclear wheth... BACKGROUND Several reports show that two types of coronary vasospasm(diffuse and focal spasm)are associated with the severity or prognosis of coronary spasm in patients with vasospastic angina(VSA).It is unclear whether intracoronary pressure differs between the two spasm types.AIM To investigate such relationships using a pressure wire during the spasm provocation test(SPT)in patients with VSA.METHODS Eighty-seven patients with VSA(average age:67 years;50 men,37 women)underwent SPT.During the SPT,a pressure wire was advanced into the distal portion of the right coronary artery and left anterior descending coronary artery,and the ratio of the intracoronary pressure to the aortic pressure(Pd/Pa)was continuously monitored.An SPT was performed using acetylcholine(ACh),and the presence of coronary spasm was defined as the presence of>90%arterial narrowing in response to an ACh infusion,with the usual chest symptoms and/or ischemic ECG changes.Focal spasm was defined as total or subtotal spasm within one segment of the AHA classification,while diffuse spasm was defined as>90%spasm with two or more segments.RESULTS Among 87 patients,the frequencies of metabolic syndrome and having coronary atherosclerosis were higher in the focal group(n=33)than in the diffuse spasm group(n=54,P<0.05).In the vessel analyses,in these 134 spastic segments,diffuse and focal spasms were detected in 100 and 34 vessels,respectively.The Pd/Pa at baseline was similar in both groups(diffuse:0.96±0.05,focal:0.95±0.05,P=0.35);however,the Pd/Pa during coronary spasm was lower in focal spastic vessels(0.66±0.20)than in diffuse spastic vessels(0.76±0.11,P<0.01),and the reduction in Pd/Pa during an SPT was also lower in focal spastic vessels(-0.29±0.20)than in diffuse spastic vessels(-0.18±0.11,P<0.01).The presence of focal spasm was a significant factor responsible for reduction in Pd/Pa during SPT.CONCLUSION These findings suggest that focal spasm may be more severe than diffuse spasm,judging from the intracoronary pressure during coronary spasm. 展开更多
关键词 ACETYLCHOLINE intracoronary pressure Diffuse or focal spasm Vasospastic angina
下载PDF
对比冠状动脉内注射替奈普酶与替罗非班对急性ST段抬高型心肌梗死的有效性及安全性
3
作者 张磊 李新 郭振峰 《临床荟萃》 CAS 2024年第7期598-602,共5页
目的观察对比冠状动脉内靶向应用替奈普酶和替罗非班对急性ST段抬高型心肌梗死(ST segment elevation myocardial infarction,STEMI)的有效性及安全性。方法回顾性分析2021年8月-2023年8月南京医科大学附属明基医院接受直接经皮冠状动... 目的观察对比冠状动脉内靶向应用替奈普酶和替罗非班对急性ST段抬高型心肌梗死(ST segment elevation myocardial infarction,STEMI)的有效性及安全性。方法回顾性分析2021年8月-2023年8月南京医科大学附属明基医院接受直接经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)的STEMI患者46例,根据治疗方案分为观察组(冠状动脉内注射替奈普酶)21例,对照组(冠状动脉内注射替罗非班)25例。比较两组支架个数、心肌梗死溶栓试验(thrombolysis in myocardial infarction,TIMI)血流分级、TIMI血栓分级、校正的TIMI血流帧数计数(CTFC)、手术后2 hST段回落幅度(STR)≥50%百分比、术后N-末端B型脑钠肽前体(N-terminal pro-brain natriuretic peptide,NT-proBNP)、术后72 h左室射血分数、住院期间出血事件和心血管不良事件发生率。结果有效性方面,给药后观察组TIMI血栓分级、CTFC均优于对照组(P<0.05),观察组术后左室射血分数、术后NT-proBNP均优于对照组(P<0.05),两组支架个数、TIMI血流分级、术后2 hSTR≥50%占比差异均无统计学意义(P>0.05);安全性方面,两组住院期间出血事件、心血管不良事件发生率差异均无统计学意义(P>0.05)。结论STEMI患者,PCI联合冠状动脉内注射替奈普酶和替罗非班均安全、有效,且替奈普酶优于替罗非班。 展开更多
关键词 ST段抬高型心肌梗死 经皮冠状动脉介入治疗 冠脉内注射 替奈普酶 替罗非班
下载PDF
终末期肝病模型-XI评分对急性心肌梗死冠状动脉支架植入术后患者预后的预测价值
4
作者 公方娜 单鸿伟 +3 位作者 廉明 宝璐尔 阿拉腾宝力德 关宏 《中国循证心血管医学杂志》 2024年第8期983-985,共3页
目的 探讨终末期肝病模型-XI(MELD-XI)评分对急性心肌梗死患者冠状动脉支架植入术后的预后的预测价值。方法 回顾性收集2021年1月至2022年12月于内蒙古医科大学附属医院收治的急性心肌梗死患者226例,根据入院时MELD-XI评分,将患者分为高... 目的 探讨终末期肝病模型-XI(MELD-XI)评分对急性心肌梗死患者冠状动脉支架植入术后的预后的预测价值。方法 回顾性收集2021年1月至2022年12月于内蒙古医科大学附属医院收治的急性心肌梗死患者226例,根据入院时MELD-XI评分,将患者分为高MELD-XI评分组和低MELD-XI评分组,每组各113例。比较两组患者近、远期预后。结果 与低MELD-XI评分组比较,高MELD-XI评分组患者左室射血分数(LVEF)显著降低[(51.67±7.91)%vs.(60.91±5.91)%],(P<0.001);N末端脑钠肽前体(NT-proBNP)显著增高(822.87±462.38) vs.(701.84±338.21)ng/L,(P=0.026)。与低MELD-XI评分组比较,高MELD-XI评分组患者不良结局事件的发生率显著增高(16.81%vs. 6.19%,P=0.012)。MELD-XI评分对急性心肌梗死冠状动脉支架植入术后不良结局事件具有一定的预测价值,曲线下面积为0.732,95%CI:0.671~0.798,(P<0.001)。结论 MELD-XI对于预测急性心肌梗死患者预后具有一定的参考价值。 展开更多
关键词 终末期肝病模型-XI 急性心肌梗死 心脏功能 预后 冠状动脉支架植入术
下载PDF
冠状动脉注射尿激酶原与瑞替普酶对急性心肌梗死患者炎症因子及出血事件的影响
5
作者 何智学 任强 +1 位作者 王煜 任波 《中国药物应用与监测》 CAS 2024年第5期528-531,共4页
目的 探究冠状动脉注射尿激酶原与瑞替普酶对急性心肌梗死(AMI)患者炎症因子及出血事件的影响。方法 选取四川大学华西医院营山医院2021年9月至2023年9月AMI患者94例,根据随机数字表法分为观察组、对照组,各47例。对照组给予冠状动脉注... 目的 探究冠状动脉注射尿激酶原与瑞替普酶对急性心肌梗死(AMI)患者炎症因子及出血事件的影响。方法 选取四川大学华西医院营山医院2021年9月至2023年9月AMI患者94例,根据随机数字表法分为观察组、对照组,各47例。对照组给予冠状动脉注射瑞替普酶,观察组给予冠状动脉注射尿激酶原。对比两组患者心肌灌注情况、炎症因子、出血事件及不良心血管事件。结果 治疗后,观察组血流分级(TIMI)1级、2级及3级的患者比例为17.02%(8/47)、17.02%(8/47)、65.96%(31/47),对照组TIMI1级、2级及3级的患者比例为8.51%(4/47)、19.15%(9/47)、72.34%(34/47),两组比较差异无统计学意义(U=0.842,P=0.400)。治疗后,观察组高敏C反应蛋白、白细胞介素-6及肿瘤坏死因子-α水平[分别为(2.93±1.01) mg·L^(-1)、(10.43±4.16) ng·L^(-1)、(112.67±21.36) ng·L^(-1)],与对照组[分别为(3.19±1.22) mg·L^(-1)、(11.67±4.54) ng·L^(-1)、(119.48±22.32) ng·L^(-1)]比较差异均无统计学意义(t=1.125、1.381、1.511,均P>0.05);治疗后,观察组轻度出血及不良心血管事件发生率分别为6.38%(3/47)、8.51%(4/47)均低于对照组的21.28%(10/47)、23.40%(11/47)(χ^(2)=4.374、3.887,均P<0.05),但中度出血事件发生率观察组为2.13%(1/47),对照组为6.38%(3/47),两组比较差异无统计学意义(χ^(2)=0.261,P=0.609)。结论 冠状动脉注射尿激酶原与瑞替普酶对AMI患者的心肌灌注效果相当,炎症改善作用相当,尿激酶原相较于瑞替普酶安全性更高。 展开更多
关键词 冠状动脉注射 尿激酶原 瑞替普酶 急性心肌梗死 炎症因子 出血事件
下载PDF
Evaluation of Clinical Outcomes of ses Stent in Patients with Coronary Artery Disease After Intracoronary Stenting in Small Vessels
6
作者 葛长江 吕树铮 柳弘 《心肺血管病杂志》 CAS 2010年第S1期67-67,共1页
Background:Limited data are available for sirolimus-eluting stent(SES,Cypher)implantation in patients with coronary artery disease in small vessels.The clinical longtermoutcomes of SES in patients with coronary artery... Background:Limited data are available for sirolimus-eluting stent(SES,Cypher)implantation in patients with coronary artery disease in small vessels.The clinical longtermoutcomes of SES in patients with coronary artery disease after intracoronary stenting in small vessels has not been yet evaluated. 展开更多
关键词 Evaluation of Clinical Outcomes of ses Stent in Patients with Coronary Artery Disease After intracoronary Stenting in Small Vessels
下载PDF
急性STEMI患者直接PCI时经球囊尾部于冠状动脉内注射小剂量尿激酶原的疗效
7
作者 李亚楠 张红雨 《临床荟萃》 CAS 2024年第6期518-523,共6页
目的探讨直接经皮冠状动脉介入术(percutaneous coronary intervention,PCI)时,经球囊尾部于冠状动脉内注射小剂量尿激酶原对急性重度血栓负荷ST段抬高型心肌梗死(ST-segment elevation myocardial infarction,STEMI)患者的临床疗效。... 目的探讨直接经皮冠状动脉介入术(percutaneous coronary intervention,PCI)时,经球囊尾部于冠状动脉内注射小剂量尿激酶原对急性重度血栓负荷ST段抬高型心肌梗死(ST-segment elevation myocardial infarction,STEMI)患者的临床疗效。方法纳入2022年6月至2023年7月就诊于天津市宝坻区人民医院胸痛中心、发病时间<12 h、直接PCI时梗死相关动脉为重度血栓负荷(血栓积分≥4分)的急性STEMI患者122例,采用随机数字表法将患者分为经球囊尾部于冠状动脉内注射尿激酶原+替罗非班组(研究组,61例)和单纯经球囊尾部于冠状动脉内注射替罗非班组(对照组,61例)。比较两组临床资料。结果①两组年龄、性别、吸烟史、高血压病史、糖尿病病史、冠心病家族史、陈旧性心肌梗死病史、高脂血症病史、心功能分级、术前TIMI血流分级、TMPG血流分级、术前化验(肌酸激酶同工酶、超敏肌钙蛋白T、CRP、D-二聚体、B型脑钠肽、肌酐、血红蛋白)、梗死相关动脉、病变血管支数、症状至再灌注时间和血栓负荷等差异均无统计学意义(P>0.05)。②PCI后两组TIMI血流分级、TMPG血流分级、主要心血管不良事件及出血率差异均无统计学意义(P>0.05)。③术后研究组2 h心电图ST段回降率≤50%占比、超敏肌钙蛋白T峰值浓度、肌酸激酶同工酶峰值浓度、术后24 h B型脑钠肽均低于对照组,术后1周左心室射血分数高于对照组,差异均有统计学意义(P<0.05)。结论经球囊尾部于冠状动脉内注射小剂量尿激酶原能够减少重度血栓负荷急性STEMI患者的心肌损害,改善心脏功能,并且不增加患者住院期间出血风险。 展开更多
关键词 ST段抬高型心肌梗死 经皮冠状动脉介入治疗 重组人尿激酶原 替罗非班 冠脉内注射
下载PDF
冠状动脉内溶栓在急性心肌梗死冠状动脉高血栓负荷患者中的应用效果探讨
8
作者 李枝怀 《中国现代药物应用》 2024年第14期88-91,共4页
目的探究冠状动脉内溶栓在急性心肌梗死冠状动脉高血栓负荷患者中的应用效果。方法选取200例急性心肌梗死冠状动脉高血栓负荷患者,随机分为观察组(常规治疗+冠状动脉内溶栓治疗)、对照组(常规治疗),各100例。比较两组治疗效果、心功能指... 目的探究冠状动脉内溶栓在急性心肌梗死冠状动脉高血栓负荷患者中的应用效果。方法选取200例急性心肌梗死冠状动脉高血栓负荷患者,随机分为观察组(常规治疗+冠状动脉内溶栓治疗)、对照组(常规治疗),各100例。比较两组治疗效果、心功能指标[左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)、左心室射血分数(LVEF)]改善情况、临床症状评分及术后冠状动脉心肌梗死溶栓治疗实验(TIMI)血流分级。结果观察组总有效率97%高于对照组的80%(P<0.05)。观察组治疗后LVEDD(50.14±3.21)mm、LVESD(45.58±4.06)mm均较对照组的(55.36±3.48)、(50.36±4.69)mm更小,LVEF(55.81±4.41)%较对照组的(50.23±3.56)%更高(P<0.05)。观察组治疗后胸痛评分(4.42±0.74)分、呼吸困难评分(4.57±0.51)分较对照组的(3.15±0.45)、(3.30±0.33)分明显更高(P<0.05)。观察组术后冠状动脉TIMI血流分级情况优于对照组(P<0.05)。结论冠状动脉内溶栓应用在急性心肌梗死冠状动脉高血栓负荷患者中可以获得更加显著的治疗效果,有利于改善心功能,减轻临床症状。 展开更多
关键词 冠状动脉内溶栓 急性心肌梗死 冠状动脉高血栓负荷
下载PDF
系统免疫炎症指数对冠状动脉支架植入术后的心肌梗死患者并发支架内血栓的预测价值
9
作者 杨凯 张羽 《中国循证心血管医学杂志》 2024年第6期690-693,共4页
目的探讨系统免疫炎症指数对冠状动脉支架植入术后的心肌梗死患者并发支架内血栓的预测价值。方法回顾性收集联勤保障部队第九四○医院于2021年1月至2022年6月收治的因心肌梗死行冠状动脉支架植入术患者462例,对其随访1年,根据患者是否... 目的探讨系统免疫炎症指数对冠状动脉支架植入术后的心肌梗死患者并发支架内血栓的预测价值。方法回顾性收集联勤保障部队第九四○医院于2021年1月至2022年6月收治的因心肌梗死行冠状动脉支架植入术患者462例,对其随访1年,根据患者是否发生支架内血栓,分为支架内血栓组(n=54)和对照组(n=408)。观察两组患者的临床特征,使用ROC曲线分析系统免疫炎症指数对冠状动脉支架植入术后的心肌梗死患者并发支架内血栓的预测价值。结果两组患者年龄、糖尿病、支架数目、药物依从性和系统免疫炎症指数等方面比较,有统计学差异(P<0.05)。系统免疫炎症指数对支架内血栓具有较好的预测价值,曲线下面积为0.786(95%CI:0.725~0.846,P=0.000),最佳诊断界值为653,此时敏感性和特异性分别为0.704和0.686。多因素回归分析显示糖尿病、未规律服药、支架数目≥2和系统免疫炎症指数≥653,是冠状动脉支架植入术后支架内血栓形成的独立危险因素(P<0.05)。与对照组比较,支架内血栓组患者再发心肌梗死发生率显著增高(33.33%vs.13.24%,P=0.000);死亡率显著增高(11.11%vs.2.70%,P=0.002)。结论系统免疫炎症指数对冠状动脉支架植入术后的心肌梗死患者并发支架内血栓具有一定预测价值。 展开更多
关键词 冠状动脉支架植入术 系统免疫炎症指数 心肌梗死 支架内血栓
下载PDF
Risk factors and outcomes of acute kidney injury after intracoronary stent implantation 被引量:11
10
作者 Fei He Jun Zhang +4 位作者 Zhong-qiu Lu Qing-ling Gao Du-juan Sha Li-gang Pei Guo-feng Fan 《World Journal of Emergency Medicine》 CAS 2012年第3期197-201,共5页
Acute kidney injury following percutaneous coronary intervention (PCI) is associated with a worse outcome. However, the risk factors and outcomes of acute kidney injury (AKI) in patients after intracoronary stent ... Acute kidney injury following percutaneous coronary intervention (PCI) is associated with a worse outcome. However, the risk factors and outcomes of acute kidney injury (AKI) in patients after intracoronary stent implantation are still unknown. A retrospective case control study was done in 325 patients who underwent intracoronary stent implantation from January 2010 to March 2011 at the Drum Tower Hospital of Nanjing University School of Medicine. Those were excluded from the study if they had incomplete clinical data. The patients were divided into a normal group and a AKI group according to the standard of post-operation day 7 to identify AKI. The parameters of the patients included: 1) pre-operative ones: age, gender, hypertension, diabetes mellitus, cerebrovascular disease, left ventricular insufficiency, peripheral angiopathy, creatinine, urea nitrogen, estimated glomerular filtration rate (eGFR), hyperuricemia, proteinuria, emergency operation, hydration, medications (ACEI/ARBs, statins); 2) intraoperative ones: dose of contrast media, operative time, hypotension; and 3) postoperative one: hypotension. The parameters were analyzed with univariate analysis and multivariate logistical regression analysis. Of the 325 patients, 51(15.7%) developed AKI. Hospital day and in-hospital mortality were increased significantly in the AKI-group. Univariate analysis showed that age, pre-operative parameters (left ventricular insufficiency, peripheral angiopathy, creatinine, urea nitrogen, estimated glomerular filtration rate, hyperuricemia, proteinuria, hydration), emergency operation, intraoperative parameters (operative time, hypotension) and postoperative hypotension were significantly different. However, multivariate logistic regression analysis revealed that increased age (OR=0.253, 95%CI=0.088-0.727), pre-operative proteinuria (OR=5.351, 95%CI=2.128-13.459), pre-operative left ventricular insufficiency (OR=8.704, 95%CI=3.170-23.898), eGFR〈60 ml/min/1.73 m2 (OR=6.677, 95%CI=1.167-38.193), prolonged operative time, intraoperative hypotension (OR=25.245, 95%CI=1.001-1.034) were independent risk factors ofAKl. AKI is a common complication and associated with ominous outcome following intracoronary stent implantation. Increased age, pre-operative proteinuria, pre-operative left ventricular insufficiency, pre-operative low estimated glomerular filtration rate, prolonged operative time, intraoperative hypotension were the significant risk factors ofAKl. 展开更多
关键词 intracoronary stent implantation Acute kidney injury Risk factor OUTCOME
下载PDF
INTRACORONARY STENT PLACEMENT IN THE RECOVERY PERIOD AFTER ACUTE MYOCARDIAL INFARCTION 被引量:2
11
作者 Liu Yin Gao Jing Dazhan Qu.Chest Hospital,Tian jin,300051,China 《中国介入心脏病学杂志》 1998年第4期158-158,共1页
Angiography and intracoronary arena was performed in 16 patients in therecovery period after acute myocardial infarction in our hospital fromNovember 1995 to October 1997.The group comprised 16 men.mean age was52.7... Angiography and intracoronary arena was performed in 16 patients in therecovery period after acute myocardial infarction in our hospital fromNovember 1995 to October 1997.The group comprised 16 men.mean age was52.7±11.8 years.Six had postinfarction angina,ten had postinfarction heartfailure.The infart-related vessel was single in 15 cases.8 in LAD.5 inRCA.2 in LCX,infact-related veasel was double in 1 case,LAD+RCA.MeanLesion length was 19.5±5.3mm and average diameter stenosis beforeprocedure was 92.5±5.1%.Nineteen intracoronary atents were implanted.10in LAD.7 in RCA,2 in LCX.Three patients received 2 stents,respectively.The procedure succese rate was 100%.After the stente implanting,averagediameter stenosis decreased to 0-10%.postinfarct angina disappeared,In thepostinfart heartfailure group,the diameter of left atrial and left vertricularon the UCG were reduced,enjection fraction increased significantly.Ourresults indicate that intracoronary stent in the recovery period aftermyocadial infarction provides a benefial effcct in increasing coronary bloodflow.preventing left ventricular function and reducing mortality Ascompared with sngioplasty.coronary stent placement has a higher clinicalsuccses rate and reduces the incidence of reetenosis. 展开更多
关键词 acute MYOCARDIAL INFARCTION postinfarctionanina PTCA intracoronary STENT
下载PDF
Intracoronary brachytherapy for the treatment of recurrent drugeluting stent in-stent restenosis:A systematic review and metaanalysis
12
作者 Irtqa Ilyas Ashish Kumar +6 位作者 Devina Adalja Mariam Shariff Rupak Desai Yasar Sattar Saraschandra Vallabhajosyula Nageshwara Gullapalli Rajkumar Doshi 《World Journal of Cardiology》 2021年第4期95-102,共8页
BACKGROUND We performed a meta-analysis on observational studies since randomized control trials are not available.We studied intracoronary brachytherapy(ICBT)and recurrent drug eluting stent in-stent restenosis(DES-I... BACKGROUND We performed a meta-analysis on observational studies since randomized control trials are not available.We studied intracoronary brachytherapy(ICBT)and recurrent drug eluting stent in-stent restenosis(DES-ISR)to evaluate the procedural success,target lesion revascularization(TLR),incidence of myocardial infarction(MI)and all-cause mortality at 2 years follow-up.AIM To perform meta-analysis for patients undergoing ICBT for recurrent DES-ISR.METHODS We performed a systematic search of the PubMed/MEDLINE,Cochrane and DARE databases to identify relevant articles.Studies were excluded if intracoronary brachytherapy was used as a treatment modality for initial ISR and studies with bare metal stents.We used a random-effect model with DerSimonian&Laird method to calculate summary estimates.Heterogeneity was assessed using I2 statistics.RESULTS A total of 6 observational studies were included in the final analysis.Procedural angiographic success following intra-coronary brachytherapy was 99.8%.Incidence of MI at 1-year was 2%and 4.1%at 2-years,respectively.The incidence of TLR 14.1%at 1-year and 22.7%at 2-years,respectively.All-cause mortality at 1-and 2-year follow-up was 3%and 7.5%,respectively.CONCLUSION Given the observational nature of the studies included in the analysis,heterogeneity was significantly higher for outcomes.While there are no randomized controlled trials or definitive guidelines available for recurrent ISR associated with DES,this analysis suggests that brachytherapy might be the alternative approach for recurrent DES-ISR.Randomized controlled trials are required to confirm results from this study. 展开更多
关键词 intracoronary brachytherapy In-stent restenosis META-ANALYSIS Drug eluting stent Systematic review BRACHYTHERAPY
下载PDF
Comparison of the curative effect of intracoronary retrograde thrombolysis and thrombus aspiration combined with stent implantation on STEMI patients
13
作者 Yan-Zi Lin Tian-Fa Li +4 位作者 Yu-Zhuo Zhang Yi-Ting Chen Ya-Ni Yan Zhe-Zun Wang Fu-Qing Guan 《Journal of Hainan Medical University》 2022年第5期23-28,共6页
Objective:To evaluate the short-term and long-term curative effects of precise intracoronary retrograde thrombolysis combined with stent implantation,thrombus aspiration combined with stent implantation,and traditiona... Objective:To evaluate the short-term and long-term curative effects of precise intracoronary retrograde thrombolysis combined with stent implantation,thrombus aspiration combined with stent implantation,and traditional stent implantation in patients with acute ST-segment elevation myocardial infarction.Methods:From January 2018 to October 2019,184 patients diagnosed with acute ST-segment elevation myocardial infarction and infarction-related arterial blood flow TIMI 0 grade in the First Affiliated Hospital of Hainan Medical College and percutaneous coronary intervention(PCI)were selected.According to different surgical methods,patients were divided into intracoronary retrograde thrombolysis combined with stent implantation group(thrombolysis group,n=57 cases),thrombus aspiration combined with stent implantation group(aspiration group,n=57 cases)),traditional stent implantation group(traditional group,n=70 cases).Compare the incidence of no-reflow phenomenon after percutaneous coronary intervention,the rate of 1 hour ST_segment fall≥50%in the ECG after PCI,and the main adverse cardiovascular events(MACE)during hospitalization;compare the left ventricular end-diastolic diameter(LVEDD)、left ventricular ejection fraction(LVEF)and major adverse cardiovascular events at 1 year after PCI.Results:1.The short-term effects:The incidence of no-reflow phenomenon in the thrombolytic group was lower than that of the aspiration group and the traditional group,and the rate of 1hSTR≥50%was higher than that of the aspiration group and the traditional group,the difference was statistically significant(P<0.05).2.The long-term effects:1 year after percutaneous coronary intervention,the LVEDD of the thrombolytic group was lower than that of the aspiration group and the traditional group,while the LVEF was higher than the aspiration group and the traditional group,and the incidence of major adverse cardiovascular events in the thrombolytic group at was lowest,both the difference was statistically significant(P<0.05).Conclusion:The application of intracoronary retrograde thrombolysis combined with stent implantation in STEMI patients can reduce the occurrence of no-reflow,improve long-term cardiac function,and reduce the occurrence of major adverse cardiovascular events for short-term and long-term. 展开更多
关键词 ST-segment elevat ion acute myocardial infarction intracoronary retrograde thrombolysis Percutaneous coronary intervention
下载PDF
A CLINICAL ANALYSIS OF 24 PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH PTCA AND INTRACORONARY STENT IMPLANTATION
14
作者 Zhengdi Chen.The Second Affiliated Hospital of Qingdao Medical College,266042,China Tianchang Li Red Cross Chaoyang Hospital,Beijing 100020,China 《中国介入心脏病学杂志》 1998年第4期157-157,共1页
The data of 24 cases(18men,6women) with AMI treated with directPTCA and intracoronary stant implantation were analyzed.The infart-related vessels were 13 LADs,4LCXs,7KCAs:The successful rate washigh(95.8%).The mean st... The data of 24 cases(18men,6women) with AMI treated with directPTCA and intracoronary stant implantation were analyzed.The infart-related vessels were 13 LADs,4LCXs,7KCAs:The successful rate washigh(95.8%).The mean stenoses before and after performation were 95.6±5.4%,8.3±0.2%.18 stems were implanted in 16 cases.Lesscomplication happened during the procedure.There was a higher TIMI Ⅲflow patency rate in PTCA and intracoronary stent implantation than indrug thrombolysis (92% vs 40%).Stent implantation had a significanteffect on myocardial reperfution by enhancing the successful rate ofPTCA and reducing the stenosis significantly. 展开更多
关键词 acute MYOCARDIAL INFARCTION PTCA intracoronary STENT implantation
下载PDF
冠状动脉内影像学检查指导经皮冠状动脉介入术应用进展 被引量:1
15
作者 马国栋 周力 沈爱东 《临床和实验医学杂志》 2023年第12期1342-1344,F0003,共4页
冠状动脉内影像学检查不仅有助于精确评价冠状动脉管腔和病变解剖,而且为制定经皮冠状动脉介入术策略和优化结果、减少并发症和不良事件提供了有力的支持。本文对目前广泛应用于临床的两种冠状动脉内影像学检查(血管内超声和光学相干断... 冠状动脉内影像学检查不仅有助于精确评价冠状动脉管腔和病变解剖,而且为制定经皮冠状动脉介入术策略和优化结果、减少并发症和不良事件提供了有力的支持。本文对目前广泛应用于临床的两种冠状动脉内影像学检查(血管内超声和光学相干断层显像)从原理、规范化应用、循证医学证据及优缺点比较进行综述,以便心血管医师正确掌握及合理应用这两种冠状动脉内影像学检查技术。 展开更多
关键词 冠状动脉内影像学 经皮冠状动脉介入术 进展
下载PDF
直接冠脉内注射替罗非班在急诊PCI治疗心肌梗死患者中的应用效果
16
作者 张培勇 郭长磊 +1 位作者 连冰 郭永龙 《临床医学工程》 2023年第6期807-808,共2页
目的探讨直接冠脉内注射替罗非班在急诊PCI治疗心肌梗死患者中的应用效果。方法80例急性心肌梗死患者随机分为对照组(急诊PCI治疗)和观察组(急诊PCI治疗+直接冠脉内注射替罗非班),比较两组的治疗效果。结果治疗后,观察组的冠脉再通率、S... 目的探讨直接冠脉内注射替罗非班在急诊PCI治疗心肌梗死患者中的应用效果。方法80例急性心肌梗死患者随机分为对照组(急诊PCI治疗)和观察组(急诊PCI治疗+直接冠脉内注射替罗非班),比较两组的治疗效果。结果治疗后,观察组的冠脉再通率、ST段抬高回落程度高于对照组,心功能指标水平均优于对照组,不良事件发生率低于对照组(P<0.05)。结论直接冠脉内注射替罗非班可提高急诊PCI治疗急性心肌梗死患者的冠脉再通率与ST段抬高回落程度,提高患者的心功能。 展开更多
关键词 替罗非班 冠脉注射 急诊PCI 心肌梗死 心功能
下载PDF
护理配合冠脉内逆向溶栓联合支架植入术的效果研究 被引量:1
17
作者 银山华 胡明 +9 位作者 卢海辉 田禹 廖以超 周星儿 郭宇婷 王凤启 郭毅 田进文 王琳 沈明志 《中国全科医学》 北大核心 2023年第S01期61-63,共3页
目的探讨急性ST段抬高型心肌梗死(STEMI)患者绕行急诊、绕行监护室直接行冠脉内逆向溶栓(ICART)联合经皮冠状动脉介入术(PCI)护理配合的重要性。方法回顾性分析2017年4—12月解放军总医院海南医院收治的25例急性STEMI患者双绕行直接入... 目的探讨急性ST段抬高型心肌梗死(STEMI)患者绕行急诊、绕行监护室直接行冠脉内逆向溶栓(ICART)联合经皮冠状动脉介入术(PCI)护理配合的重要性。方法回顾性分析2017年4—12月解放军总医院海南医院收治的25例急性STEMI患者双绕行直接入导管室行ICART联合PCI治疗的病例资料、救治过程、护理措施,分析护理配合对提升ICART联合PCI成功率的意义。结果患者均完成ICART联合PCI手术,康复出院。结论迅速实施ICART+PCI是手术成功的关键;密切观察、术中默契配合是手术成功的保证。高质量护理配合对提升双绕行急性心肌梗死患者ICART+PCI手术成功率起到很大的支撑作用。 展开更多
关键词 ST段抬高型心肌梗死 急性心肌梗死 冠脉内逆向溶栓 双绕行 急诊手术 护理
下载PDF
STEMI患者急诊PCI后无复流的相关因素及冠脉内联合药物干预效果分析
18
作者 张国瑞 张静 +4 位作者 杜超 刘莉莉 秦利强 江平 王立君 《医学理论与实践》 2023年第2期190-193,204,共5页
目的:探讨急性ST段抬高型心肌梗死(STEMI)患者行急诊PCI后发生无复流现象(NRP)的相关因素及冠脉内联合应用尼可地尔及重组人尿激酶原(rh-proUK)的干预效果分析。方法:选择我院2019年3月—2021年1月收治的180例行急诊PCI的STEMI患者,按... 目的:探讨急性ST段抬高型心肌梗死(STEMI)患者行急诊PCI后发生无复流现象(NRP)的相关因素及冠脉内联合应用尼可地尔及重组人尿激酶原(rh-proUK)的干预效果分析。方法:选择我院2019年3月—2021年1月收治的180例行急诊PCI的STEMI患者,按照术后是否发生NRP将其分为NRP组(n=60)和正常血流组(n=120)两组,采用多因素Logistic回归法对STEMI行急诊PCI后NRP的相关因素进行分析。并随机数字法将NRP组患者分对照组和观察组,每组30例。其中对照组常规治疗,观察组在常规治疗基础上冠脉内给予尼可地尔联合rh-proUK治疗。比较两组患者治疗前后心肌再灌注、心功能等指标变化,并观察两组术后6个月的主要不良心血管事件(MACEs)及出血等不良反应。结果:发病再灌注时间、肌钙蛋白T峰值、收缩压、糖尿病及球囊扩张次数为STEMI患者行急诊PCI后NRP的危险因素(P<0.05)。与治疗前相比,观察组和对照组患者治疗后LVEF、E/A明显升高,LVEDD明显降低,且观察组改善更显著(P<0.05)。观察组受试者心电图ST段回落率、TMPG 3级、TIMI血流分级3级例数明显高于对照组,cTFC值明显低于对照组;观察组患者术后MACEs发生率明显低于对照组(P<0.05)。结论:发病再灌注时间、肌钙蛋白T峰值、收缩压、球囊扩张次数及糖尿病是STEMI患者行急诊PCI术后NRP的相关因素,冠脉内联合应用尼可地尔及rh-proUK治疗可显著改善NRP患者心脏功能、心肌血流灌注,降低MACEs发生风险,具有一定的临床应用价值。 展开更多
关键词 STEMI 急诊PCI 无复流现象 影响因素 冠脉内药物干预
下载PDF
冠状动脉钙化结节研究进展 被引量:2
19
作者 王威 赖图雅 +4 位作者 王宁远 王鑫焱 辛倩 陈韵岱 高磊 《中国介入心脏病学杂志》 CSCD 2023年第2期133-137,共5页
冠状动脉钙化结节是导致急性冠状动脉综合征的原因之一,在特定群体中出现的概率并不低,且容易导致主要不良心血管事件。随着腔内影像技术和斑块修饰技术的发展,对钙化结节的诊断和治疗较既往有了明显的进步,但仍需进一步规范。本文就冠... 冠状动脉钙化结节是导致急性冠状动脉综合征的原因之一,在特定群体中出现的概率并不低,且容易导致主要不良心血管事件。随着腔内影像技术和斑块修饰技术的发展,对钙化结节的诊断和治疗较既往有了明显的进步,但仍需进一步规范。本文就冠状动脉钙化结节的研究进展作一综述。 展开更多
关键词 钙化结节 冠状动脉粥样硬化性心脏病 腔内影像 斑块修饰
下载PDF
冠状动脉内注射尼可地尔对心肌梗死经皮冠状动脉介入术中无复流现象的干预价值 被引量:2
20
作者 曹现霞 陈旭 《中外医疗》 2023年第5期13-17,共5页
目的 探讨冠状动脉内注射尼可地尔在心肌梗死经皮冠状动脉介入术中无复流现象中的临床应用价值。方法 随机选取2020年1—12月日照心脏病医院收治的急性非ST段抬高型心肌梗死患者80例为研究对象,按照随机数字表法分为观察组和对照组,各4... 目的 探讨冠状动脉内注射尼可地尔在心肌梗死经皮冠状动脉介入术中无复流现象中的临床应用价值。方法 随机选取2020年1—12月日照心脏病医院收治的急性非ST段抬高型心肌梗死患者80例为研究对象,按照随机数字表法分为观察组和对照组,各40例。观察组于冠状动脉中注入尼可地尔,对照组于冠状动脉中注入硝酸甘油,比较两组血清脑钠肽(BNP)水平、左室射血分数变化和心肌梗塞溶栓血流分级(TIMI)变化情况,统计两组住院期间不良心血管事件,比较两组再次冠状动脉造影提示冠状动脉管腔狭窄比例及斑块长度。随访1个月比较两组内皮生长因子(VEGF)、内皮素-1(ET-1)。结果 治疗后,观察组左室射血分数为(58.8±9.8)%高于对照组的(51.4±2.6)%,且观察组BNP水平(121.2±5.2)pg/mL低于对照组的(231.4±11.7)pg/mL,差异有统计学意义(t=4.616、54.436,P<0.05)。治疗后,观察组TIMI血流分级高于对照组,差异有统计学意义(P<0.05)。观察组住院期间不良心血管事件发生率低于对照组,差异有统计学意义(χ^(2)=9.928,P<0.05)。随访1个月时观察组VEGF水平高于对照组,ET-1水平低于对照组,差异有统计学意义(P<0.05)。观察组斑块导致管腔狭窄比例低于对照组,斑块长度短于对照组,差异有统计学意义(P<0.05)。结论 针对心肌梗死经皮冠状动脉介入治疗后无复流现象,冠状动脉内注射尼可地尔可有效改善冠状动脉血流,减少术后并发症,促进冠状动脉血管功能恢复,降低心肌梗死再发率。 展开更多
关键词 冠状动脉内 注射治疗 尼可地尔 心肌梗死 经皮冠状动脉介入 术中无复流
下载PDF
上一页 1 2 18 下一页 到第
使用帮助 返回顶部